The 2026 U.S.-Taiwan Patient Care Innovation Forum explored medical advances and policy reforms that can improve patient outcomes and help Taiwan meet the challenges of an aging society.
Moderna Taiwan is advancing mRNA science, partnerships, and local talent development to support healthcare innovation and long-term health preparedness in Taiwan.
Taiwan’s rapid shift into a super-aged society is intensifying the burden of dementia on patients, families, and the healthcare system. Earlier screening, stronger caregiver support, and emerging diagnostic tools could help Taiwan better prepare for the rising number of cases.
Taiwan has made major progress in hepatitis prevention, but chronic hepatitis B continues to drive a significant share of liver cancer cases. As new therapies, earlier intervention, and more targeted screening reshape care, stronger policy support could help Taiwan move toward the next phase of liver disease control.
Taiwan’s new cabinet-level Ministry of Sports marks a shift in how the government views athletics, linking participation, diplomacy, and industry development. The challenge now lies in turning Olympic success and public enthusiasm into lasting policy influence.
An investigation into Taiwan’s tap water uncovers a story that goes far beyond lab results. While municipal systems, especially in Taipei, meet world-class standards, trust erodes along the way through aging pipes, rooftop tanks, uneven governance, and decades of inherited caution.
Taiwan’s fight against antimicrobial resistance is entering a new phase as Taiwan CDC and Pfizer formalize a public-private partnership to strengthen surveillance, research, and public education. The new MOU underscores the urgency of AMR and aligns with Taiwan’s expanding One Health strategy.
Taiwan is placing vaccination at the heart of its Healthy Taiwan agenda, treating prevention as essential to easing pressure on the healthcare system.
Taiwan’s rising breast cancer mortality reflects gaps in early detection, complete treatment, and timely access to new therapies. Strengthening personalized screening and data-driven care policies is key to improving outcomes.
As Taiwan advances its Healthy Taiwan vision, experts from government, academia, and industry underscored that sustained investment in vaccination is essential to protecting vulnerable populations and strengthening long-term healthcare resilience.
